LYNN VANWAGNEN: Open Payments
NPI 1609833359 · JACKSON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 41 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $281 · 2025 $816
Food & beverage: $816
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $284 |
| PFIZER INC. | 8 | $179 |
| Novartis Pharmaceuticals Corporation | 6 | $124 |
| Amgen Inc. | 6 | $98 |
| Lilly USA, LLC | 4 | $69 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: Wegovy, ELIQUIS, LEQVIO, Ozempic, MOUNJARO, OTEZLA, NEFFY, EVENITY.
Industry payments across MI — which companies pay providers there.
